Dr. Schlansky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3303 S Bond Ave
Portland, OR 97239Phone+1 503-494-4373Fax+1 503-418-4189
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Transplant Hepatology, 2012 - 2013- Oregon Health & Science University (OHSU Health)Fellowship, Gastroenterology, 2009 - 2012
University of WashingtonResidency, Internal Medicine, 2006 - 2009
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2005
Certifications & Licensure
WA State Medical License 2017 - 2026
OR State Medical License 2009 - 2025- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Publications & Presentations
PubMed
- African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis.Maryam Yazdanfar, Joseph Zepeda, Richard Dean, Jialin Wu, Cynthia Levy
Hepatology Communications. 2024-02-01 - 1 citationsLow Utilization of External Beam Radiation Therapy for Patients With Unresectable Hepatocellular Carcinoma: An Analysis of the United Network for Organ Sharing Database.Tessa Herman, Andy Kaempf, Barry Schlansky, Nima Nabavizadeh
International Journal of Radiation Oncology, Biology, Physics. 2022-10-01 - 13 citationsSteroid-Resistant Acute Cellular Rejection of the Liver After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination.Ross Vyhmeister, C. Kristian Enestvedt, Mandy VanSandt, Barry Schlansky
Liver Transplantation. 2021-05-16
Press Mentions
Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance from the American Association for the Study of Liver DiseasesJanuary 21st, 2020
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver DiseasesNovember 6th, 2018
Routine Hospital Tool Found to Predict Poor Outcomes After Liver TransplantationAugust 10th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
